Cargando…

Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay

INTRODUCTION: Buruli ulcer (BU) caused by Mycobacterium ulcerans is effectively treated with rifampicin and streptomycin for 8 weeks but some lesions take several months to heal. We have shown previously that some slowly healing lesions contain mycolactone suggesting continuing infection after antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarpong-Duah, Mabel, Frimpong, Michael, Beissner, Marcus, Saar, Malkin, Laing, Ken, Sarpong, Francisca, Loglo, Aloysius Dzigbordi, Abass, Kabiru Mohammed, Frempong, Margaret, Sarfo, Fred Stephen, Bretzel, Gisela, Wansbrough-Jones, Mark, Phillips, Richard Odame
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510892/ https://www.ncbi.nlm.nih.gov/pubmed/28671942 http://dx.doi.org/10.1371/journal.pntd.0005695

Ejemplares similares

Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load
por: Frimpong, Michael, et al.
Publicado: (2019)

IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection
por: Loglo, Aloysius D., et al.
Publicado: (2018)

Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana
por: Phillips, Richard O., et al.
Publicado: (2014)

Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
por: Amoako, Yaw Ampem, et al.
Publicado: (2021)

Detection of Viable Mycobacterium ulcerans in Clinical Samples by a Novel Combined 16S rRNA Reverse Transcriptase/IS2404 Real-Time qPCR Assay
por: Beissner, Marcus, et al.
Publicado: (2012)

Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assay
por: Frimpong, Michael, et al.
Publicado: (2019)

Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease
por: Sarfo, Fred Stephen, et al.
Publicado: (2015)

Variable Number Tandem Repeat Profiling of Mycobacterium ulcerans Reveals New Genotypes in Buruli Ulcer Endemic Communities in Ghana and Côte d’Ivoire
por: Gyamfi, Elizabeth, et al.
Publicado: (2022)

Genetic Diversity of PCR-Positive, Culture-Negative and Culture-Positive Mycobacterium ulcerans Isolated from Buruli Ulcer Patients in Ghana
por: Williamson, Heather, et al.
Publicado: (2014)

Combined Inflammatory and Metabolic Defects Reflected by Reduced Serum Protein Levels in Patients with Buruli Ulcer Disease
por: Phillips, Richard O., et al.
Publicado: (2014)

A Severe Case of Buruli Ulcer Disease with Pleural Effusions
por: Sarfo, Fred S., et al.
Publicado: (2014)

Rapid Extraction Method of Mycobacterium ulcerans DNA from Clinical Samples of Suspected Buruli Ulcer Patients
por: Frimpong, Michael, et al.
Publicado: (2019)

Loop-Mediated Isothermal Amplification for Laboratory Confirmation of Buruli Ulcer Disease—Towards a Point-of-Care Test
por: Beissner, Marcus, et al.
Publicado: (2015)

Molecular detection of Mycobacterium ulcerans in the environment and its relationship with Buruli ulcer occurrence in Zio and Yoto districts of maritime region in Togo
por: Maman, Issaka, et al.
Publicado: (2018)

Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports
por: Amoako, Y. A., et al.
Publicado: (2019)

Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region
por: Maman, Issaka, et al.
Publicado: (2018)

Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
por: Phillips, Richard Odame, et al.
Publicado: (2015)

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease
por: Niang, Fatoumata, et al.
Publicado: (2015)

Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression
por: Nausch, Norman, et al.
Publicado: (2017)

Treatment Outcome of Patients with Buruli Ulcer Disease in Togo
por: Beissner, Marcus, et al.
Publicado: (2015)

Caregiver burden in Buruli ulcer disease: Evidence from Ghana
por: Amoako, Yaw Ampem, et al.
Publicado: (2021)

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
por: Phillips, Richard O, et al.
Publicado: (2020)

Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa
por: Wadagni, Anita C., et al.
Publicado: (2019)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

The Incubation Period of Buruli Ulcer (Mycobacterium ulcerans Infection)
por: Trubiano, Jason A., et al.
Publicado: (2013)

Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
por: Yotsu, Rie R, et al.
Publicado: (2018)

Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease
por: Sarfo, Fred S, et al.
Publicado: (2014)

Spontaneous Clearance of Mycobacterium ulcerans in a Case of Buruli Ulcer
por: Gordon, Claire L., et al.
Publicado: (2011)

Mycobacterium ulcerans DNA Not Detected in Faecal Samples from Buruli Ulcer Patients: Results of a Pilot Study
por: Sarfo, Fred S., et al.
Publicado: (2011)

RLEP LAMP for the laboratory confirmation of leprosy: towards a point-of-care test
por: Saar, Malkin, et al.
Publicado: (2021)

Mental health and quality of life burden in Buruli ulcer disease patients in Ghana
por: Amoako, Yaw Ampem, et al.
Publicado: (2021)

Aquatic Insects and Mycobacterium ulcerans: An Association Relevant to Buruli Ulcer Control?
por: Silva, Manuel T, et al.
Publicado: (2007)

Risk of Buruli Ulcer and Detection of Mycobacterium ulcerans in Mosquitoes in Southeastern Australia
por: Lavender, Caroline J., et al.
Publicado: (2011)

Detection of Mycobacterium ulcerans in the Environment Predicts Prevalence of Buruli Ulcer in Benin
por: Williamson, Heather R., et al.
Publicado: (2012)

Linking the Mycobacterium ulcerans environment to Buruli ulcer disease: Progress and challenges
por: Dhungel, Laxmi, et al.
Publicado: (2021)

Impact of Mycobacterium ulcerans Biofilm on Transmissibility to Ecological Niches and Buruli Ulcer Pathogenesis
por: Marsollier, Laurent, et al.
Publicado: (2007)

Mycobacterium ulcerans in Mosquitoes Captured during Outbreak of Buruli Ulcer, Southeastern Australia
por: Johnson, Paul D.R., et al.
Publicado: (2007)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans
por: Zingue, Dezemon, et al.
Publicado: (2018)

Seasonal Pattern of Mycobacterium ulcerans, the Causative Agent of Buruli Ulcer, in the Environment in Ghana
por: Aboagye, Samuel Yaw, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4203isn8siufgpgpquludeilo0